Daily Archives: April 26, 2019

EU Panel Backs Dolutegravir/Lamivudine Combo Pill for HIV

Dovato contains 50 mg dolutegravir and 300 mg lamivudine and would be the first once-daily, single-pill, completed 2-drug regimen for treatment of HIV in Europe. International Approvals …read more

FDA OKs New Topical Treatment Duobrii for Plaque Psoriasis

Duobrii lotion is the first and only topical lotion that combines halobetasol propionate and tazarotene in one formulation. FDA Approvals …read more

Patterns of antibiotic use may predict cardiovascular risk

A large cohort study has found a link between prolonged antibiotic use in middle age and later in life and an increased cardiovascular risk. …read more